Kintara Therapeutics News

KTRADelisted Stock  USD 6.30  0.14  2.17%   
About 62% of Kintara Therapeutics' investor base is looking to short. The analysis of current outlook of investing in Kintara Therapeutics suggests that many traders are alarmed regarding Kintara Therapeutics' prospects. The current market sentiment, together with Kintara Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Kintara Therapeutics stock news signals to limit their universe of possible portfolio assets.
  
over two months ago at news.google.com         
Kintara Therapeutics modifies merger terms with TuHURA Biosciences - Investing.com India
Google News at Macroaxis
over two months ago at news.google.com         
Kintara Therapeutics modifies merger terms with TuHURA Biosciences - Investing.com
Google News at Macroaxis
over two months ago at finance.yahoo.com         
Kintara Therapeutics Announces Adjournment of Special Meeting of Stockholders until October 4, 2024
Yahoo News
over two months ago at investors.com         
Amphastar Pharm Sees Composite Rating Climb To 97
Investors Business Daily at Macroaxis
over two months ago at prnewswire.com         
Tetra Pharm Technologies Relocates to Copenhagen Towers
prnewswire News
over two months ago at finance.yahoo.com         
Kintara Therapeutics Reminds Stockholders to Vote by Thursday to Allow for Completion of the Propose...
Yahoo News
over two months ago at prnewswire.com         
Tetra Pharm Technologies se traslada a Copenhagen Towers
prnewswire News
over three months ago at simplywall.st         
Hanmi Pharm. Co., Ltd.s largest shareholders are public companies with 42 percent ownership, individ...
Simply Wall St News at Macroaxis
over three months ago at finance.yahoo.com         
Kintara Therapeutics Provides Update on Corporate Developments and REM-001 Clinical Study
Yahoo News
over three months ago at simplywall.st         
Declining Stock and Solid Fundamentals Is The Market Wrong About High Tech Pharm Co., Ltd.?
Simply Wall St News at Macroaxis
over three months ago at finance.yahoo.com         
Kintara Therapeutics to Hold Special Meeting of Stockholders to Allow for Completion of the Proposed...
Yahoo News
over three months ago at news.google.com         
Kintara Therapeutics Announces Special Meeting for TuHURA Merger - TipRanks
Google News at Macroaxis
over three months ago at simplywall.st         
Earnings Working Against Sam-A Pharm. Co., Ltds Share Price Following 34 percent Dive
Simply Wall St News at Macroaxis
over three months ago at finance.yahoo.com         
TuHURA Biosciences and Kintara Therapeutics Announce Kineta Inc. Reopens Enrollment for VISTA-101 Cl...
Yahoo News
over three months ago at ndtv.com         
India Rankings 2024 Explore Top 10 Pharmacy Colleges
news
Far too much social signal, news, headlines, and media speculation about Kintara Therapeutics that are available to investors today. That information is available publicly through Kintara media outlets and privately through word of mouth or via Kintara internal channels. However, regardless of the origin, that massive amount of Kintara data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Kintara Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Kintara Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Kintara Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Kintara Therapeutics alpha.

Kintara Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Kintara Therapeutics to Hold Special Meeting of Stockholders to Allow for Completion of the Proposed Merger with TuHURA Biosciences, Inc.
09/09/2024
2
Tetra Pharm Technologies Relocates to Copenhagen Towers
09/18/2024
3
Amphastar Pharm Sees Composite Rating Climb To 97
09/19/2024
4
Kintara Therapeutics modifies merger terms with TuHURA Biosciences - Investing.com India
09/26/2024
5
Individual investors who hold 55 percent of Hainan Poly Pharm. Co., Ltd gained 29, insiders profited as well
10/04/2024
6
Innovent and Ask Pharm Announce Strategic Collaboration for Limertinib, a Third-generation EGFR TKI for the Treatment of Lung Cancer
10/08/2024
7
IBD Rating Upgrades Amphastar Pharm Flashes Improved Relative Price Strength
10/15/2024
8
Amphastar Pharm Joins Elite List Of Stocks With 95-Plus Composite Rating
10/17/2024
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Consideration for investing in Kintara Stock

If you are still planning to invest in Kintara Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kintara Therapeutics' history and understand the potential risks before investing.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
FinTech Suite
Use AI to screen and filter profitable investment opportunities